| Year |
Citation |
Score |
| 2023 |
Rød BE, Wergeland S, Bjørnevik K, Holmøy T, Ulvestad E, Njølstad G, Myhr KM, Torkildsen Ø. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy. Multiple Sclerosis and Related Disorders. 79: 105037. PMID 37804765 DOI: 10.1016/j.msard.2023.105037 |
0.329 |
|
| 2023 |
Kapali A, Daltveit AK, Myhr KM, Bjornevik K, Baldin E, Pugliatti M, Riise T, Cortese M. Childbirth delivery mode and the risk of multiple sclerosis: a prospective population-based study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 37479464 DOI: 10.1136/jnnp-2023-331241 |
0.318 |
|
| 2023 |
Lie IA, Rød BE, Kvistad SS, Holmøy T, Myhr KM, Torkildsen Ø, Wergeland S. Interferon β1a treatment does not influence serum Epstein-Barr virus antibodies in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. 70: 104530. PMID 36701908 DOI: 10.1016/j.msard.2023.104530 |
0.317 |
|
| 2022 |
Hallin EI, Trætteberg Serkland T, Myhr KM, Grytten Torkildsen Ø, Skrede S. Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry. Journal of Mass Spectrometry and Advances in the Clinical Lab. 25: 53-60. PMID 35910410 DOI: 10.1016/j.jmsacl.2022.07.004 |
0.322 |
|
| 2022 |
Lie IA, Kaçar S, Wesnes K, Brouwer I, Kvistad SS, Wergeland S, Holmøy T, Midgard R, Bru A, Edland A, Eikeland R, Gosal S, Harbo HF, Kleveland G, Sørenes YS, ... ... Myhr KM, et al. Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 35649699 DOI: 10.1136/jnnp-2021-328568 |
0.327 |
|
| 2022 |
Nygaard GO, Torgauten H, Skattebøl L, Høgestøl EA, Sowa P, Myhr KM, Torkildsen Ø, Celius EG. Risk of fingolimod rebound after switching to cladribine or rituximab in multiple sclerosis. Multiple Sclerosis and Related Disorders. 62: 103812. PMID 35462167 DOI: 10.1016/j.msard.2022.103812 |
0.317 |
|
| 2021 |
Grytten N, Myhr KM, Celius EG, Benjaminsen E, Kampman MT, Midgard R, Vatne A, Aarseth JH, Riise T, Torkildsen Ø. Incidence of cancer in multiple sclerosis before and after the treatment era- a registry- based cohort study. Multiple Sclerosis and Related Disorders. 55: 103209. PMID 34419754 DOI: 10.1016/j.msard.2021.103209 |
0.314 |
|
| 2021 |
Norborg H, Riise T, Myhr KM, Grytten N, Wergeland S. Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 7: 20552173211022027. PMID 34188949 DOI: 10.1177/20552173211022027 |
0.338 |
|
| 2021 |
Wesnes K, Myhr KM, Riise T, Kvistad SS, Torkildsen Ø, Wergeland S, Holmøy T, Midgard R, Bru A, Edland A, Eikeland R, Gosal S, Harbo HF, Kleveland G, Sørenes YS, et al. Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis. Multiple Sclerosis and Related Disorders. 50: 102801. PMID 33636616 DOI: 10.1016/j.msard.2021.102801 |
0.333 |
|
| 2021 |
Mosleth EF, Vedeler CA, Liland KH, McLeod A, Bringeland GH, Kroondijk L, Berven FS, Lysenko A, Rawlings CJ, Eid KE, Opsahl JA, Gjertsen BT, Myhr KM, Gavasso S. Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis. Scientific Reports. 11: 4087. PMID 33602999 DOI: 10.1038/s41598-021-82388-w |
0.35 |
|
| 2020 |
Benjaminsen E, Myhr KM, Grytten N, Alstadhaug KB. Comorbidity in multiple sclerosis patients from Nordland County, Norway - validated data from the Norwegian Patient Registry. Multiple Sclerosis and Related Disorders. 48: 102691. PMID 33360174 DOI: 10.1016/j.msard.2020.102691 |
0.358 |
|
| 2020 |
Vermersch P, Oh J, Cascione M, Oreja-Guevara C, Gobbi C, Travis LH, Myhr KM, Coyle PK. Teriflunomide vs injectable disease modifying therapies for relapsing forms of MS. Multiple Sclerosis and Related Disorders. 43: 102158. PMID 32470857 DOI: 10.1016/j.msard.2020.102158 |
0.327 |
|
| 2020 |
Røsjø E, Lindstrøm JC, Holmøy T, Myhr KM, Varhaug KN, Torkildsen Ø. Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis. Frontiers in Neurology. 11: 329. PMID 32425877 DOI: 10.3389/Fneur.2020.00329 |
0.341 |
|
| 2020 |
Bringeland GH, Myhr KM, Vedeler CA, Gavasso S. Wearing-off at the end of natalizumab dosing interval and risk of MS disease activity: A prospective 1-year follow-up study. Journal of the Neurological Sciences. 415: 116880. PMID 32413799 DOI: 10.1016/J.Jns.2020.116880 |
0.379 |
|
| 2020 |
Willumsen JS, Aarseth JH, Myhr KM, Midgard R. High incidence and prevalence of MS in Møre and Romsdal County, Norway, 1950-2018. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 32217642 DOI: 10.1212/NXI.0000000000000713 |
0.328 |
|
| 2020 |
Jacobsen C, Zivadinov R, Myhr KM, Dalaker TO, Dalen I, Bergsland N, Farbu E. Brain atrophy and employment in multiple sclerosis patients: a 10-year follow-up study. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 6: 2055217320902481. PMID 32064116 DOI: 10.1177/2055217320902481 |
0.317 |
|
| 2019 |
Burkill S, Vattulainen P, Geissbuehler Y, Sabido Espin M, Popescu C, Suzart-Woischnik K, Hillert J, Artama M, Verkkoniemi-Ahola A, Myhr KM, Cnattingius S, Korhonen P, Montgomery S, Bahmanyar S. The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis. Plos One. 14: e0227120. PMID 31887199 DOI: 10.1371/Journal.Pone.0227120 |
0.357 |
|
| 2019 |
Kvistad SAS, Lehmann AK, Trovik LH, Kristoffersen EK, Bø L, Myhr KM, Torkildsen Ø. Safety and efficacy of autologous hematopoietic stem cell transplantation for multiple sclerosis in Norway. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519893926. PMID 31833798 DOI: 10.1177/1352458519893926 |
0.34 |
|
| 2019 |
Myhr KM, Torkildsen Ø. Serum NFL levels should be used to monitor multiple sclerosis evolution - No. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519872891. PMID 31625829 DOI: 10.1177/1352458519872891 |
0.346 |
|
| 2019 |
Skorve E, Lundervold AJ, Torkildsen Ø, Myhr KM. The Norwegian translation of the brief international cognitive assessment for multiple sclerosis (BICAMS). Multiple Sclerosis and Related Disorders. 36: 101408. PMID 31610403 DOI: 10.1016/J.Msard.2019.101408 |
0.346 |
|
| 2019 |
Benjaminsen E, Myhr KM, Grytten N, Alstadhaug KB. Validation of the multiple sclerosis diagnosis in the Norwegian Patient Registry. Brain and Behavior. e01422. PMID 31583850 DOI: 10.1002/Brb3.1422 |
0.311 |
|
| 2019 |
Grytten N, Myhr KM, Celius EG, Benjaminsen E, Kampman M, Midgard R, Vatne A, Aarseth JH, Riise T, Torkildsen Ø. Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519877244. PMID 31573834 DOI: 10.1177/1352458519877244 |
0.435 |
|
| 2019 |
Varhaug KN, Torkildsen Ø, Myhr KM, Vedeler CA. Neurofilament Light Chain as a Biomarker in Multiple Sclerosis. Frontiers in Neurology. 10: 338. PMID 31024432 DOI: 10.3389/Fneur.2019.00338 |
0.403 |
|
| 2019 |
Myhr KM, Torkildsen Ø, Lossius A, Bø L, Holmøy T. B cell depletion in the treatment of multiple sclerosis. Expert Opinion On Biological Therapy. PMID 30632834 DOI: 10.1080/14712598.2019.1568407 |
0.405 |
|
| 2018 |
Magalhaes S, Pugliatti M, Riise T, Myhr KM, Ciampi A, Bjornevik K, Wolfson C. Shedding light on the link between early life sun exposure and risk of multiple sclerosis: results from the EnvIMS Study. International Journal of Epidemiology. PMID 30561654 DOI: 10.1093/Ije/Dyy269 |
0.404 |
|
| 2018 |
Kvistad SS, Myhr KM, Holmøy T, Benth JŠ, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Sagen JV, Torkildsen Ø. Serum levels of leptin and adiponectin are not associated with disease activity or treatment response in multiple sclerosis. Journal of Neuroimmunology. 323: 73-77. PMID 30196837 DOI: 10.1016/J.Jneuroim.2018.07.011 |
0.419 |
|
| 2018 |
Bhan A, Jacobsen C, Myhr KM, Dalen I, Lode K, Farbu E. Neurofilaments and 10-year follow-up in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518782005. PMID 30066611 DOI: 10.1177/1352458518782005 |
0.352 |
|
| 2018 |
Bjornevik K, Myhr KM, Beiske A, Bjerve KS, Holmøy T, Hovdal H, Midgard R, Riise T, Wergeland S, Torkildsen Ø. α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518779925. PMID 29862891 DOI: 10.1177/1352458518779925 |
0.352 |
|
| 2018 |
Svendsen B, Grytten N, Bø L, Aarseth H, Smedal T, Myhr KM. The economic impact of multiple sclerosis to the patients and their families in Norway. The European Journal of Health Economics : Hepac : Health Economics in Prevention and Care. PMID 29680926 DOI: 10.1007/S10198-018-0971-5 |
0.39 |
|
| 2018 |
Torkildsen Ø, Holmøy T, Myhr KM. Severe multiple sclerosis reactivation after gonadotropin treatment. Multiple Sclerosis and Related Disorders. 22: 38-40. PMID 29525298 DOI: 10.1016/J.Msard.2018.02.031 |
0.459 |
|
| 2018 |
Varhaug KN, Barro C, Bjørnevik K, Myhr KM, Torkildsen Ø, Wergeland S, Bindoff LA, Kuhle J, Vedeler C. Neurofilament light chain predicts disease activity in relapsing-remitting MS. Neurology(R) Neuroimmunology & Neuroinflammation. 5: e422. PMID 29209636 DOI: 10.1212/Nxi.0000000000000422 |
0.383 |
|
| 2018 |
Cortese M, Riise T, Bjørnevik K, Myhr KM. Body size and physical exercise, and the risk of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 24: 270-278. PMID 28287051 DOI: 10.1177/1352458517699289 |
0.343 |
|
| 2017 |
Olafsson S, Stridh P, Bos SD, Ingason A, Euesden J, Sulem P, Thorleifsson G, Gustafsson O, Johannesson A, Geirsson AJ, Thorsson AV, Sigurgeirsson B, Ludviksson BR, Olafsson E, Kristjansdottir H, ... ... Myhr KM, et al. Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlations. Npj Genomic Medicine. 2: 24. PMID 29263835 DOI: 10.1038/S41525-017-0027-2 |
0.414 |
|
| 2017 |
Myhr KM, Mäurer M, Ginés MM, Esposito F, Linker R. Break-out session highlights. Neurodegenerative Disease Management. 7: 45-49. PMID 29143586 DOI: 10.2217/Nmt-2017-0042 |
0.472 |
|
| 2017 |
Benjaminsen E, Myhr KM, Alstadhaug KB. The prevalence and characteristics of epilepsy in patients with multiple sclerosis in Nordland county, Norway. Seizure. 52: 131-135. PMID 29031194 DOI: 10.1016/J.Seizure.2017.09.022 |
0.434 |
|
| 2017 |
Holmøy T, Torkildsen Ø, Myhr KM. An update on cladribine for relapsing-remitting multiple sclerosis. Expert Opinion On Pharmacotherapy. 18: 1627-1635. PMID 28858531 DOI: 10.1080/14656566.2017.1372747 |
0.436 |
|
| 2017 |
Varhaug KN, Vedeler CA, Myhr KM, Aarseth JH, Tzoulis C, Bindoff LA. Increased levels of cell-free mitochondrial DNA in the cerebrospinal fluid of patients with multiple sclerosis. Mitochondrion. 34: 32-35. PMID 28017684 DOI: 10.1016/J.Mito.2016.12.003 |
0.344 |
|
| 2017 |
Bjørnevik K, Riise T, Bostrom I, Casetta I, Cortese M, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM. Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study. Multiple Sclerosis (Houndmills, Basingstoke, England). 23: 1018-1024. PMID 27663872 DOI: 10.1177/1352458516671028 |
0.367 |
|
| 2017 |
Grytten N, Skår AB, Aarseth JH, Assmus J, Farbu E, Lode K, Nyland HI, Smedal T, Myhr KM. The influence of coping styles on long-term employment in multiple sclerosis: A prospective study. Multiple Sclerosis (Houndmills, Basingstoke, England). 23: 1008-1017. PMID 27600114 DOI: 10.1177/1352458516667240 |
0.616 |
|
| 2016 |
Berger T, Elovaara I, Fredrikson S, McGuigan C, Moiola L, Myhr KM, Oreja-Guevara C, Stoliarov I, Zettl UK. Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts. Cns Drugs. PMID 27882532 DOI: 10.1007/S40263-016-0394-8 |
0.371 |
|
| 2016 |
Lereim RR, Oveland E, Xiao Y, Torkildsen Ø, Wergeland S, Myhr KM, Sun SC, Berven FS. The Brain Proteome of the Ubiquitin Ligase Peli1 Knock-Out Mouse during Experimental Autoimmune Encephalomyelitis. Journal of Proteomics & Bioinformatics. 9: 209-219. PMID 27746629 DOI: 10.4172/Jpb.1000408 |
0.302 |
|
| 2016 |
Cortese M, Riise T, Bjørnevik K, Bhan A, Farbu E, Grytten N, Hogenesch I, Midgard R, Smith Simonsen C, Telstad W, Ascherio A, Myhr KM. Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom. Annals of Neurology. 80: 616-24. PMID 27554176 DOI: 10.1002/Ana.24769 |
0.415 |
|
| 2016 |
Kvistad S, Myhr KM, Holmøy T, Benth JŠ, Løken-Amsrud KI, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Bakke SJ, Torkildsen Ø. No association of tobacco use and disease activity in multiple sclerosis. Neurology(R) Neuroimmunology & Neuroinflammation. 3: e260. PMID 27458599 DOI: 10.1212/Nxi.0000000000000260 |
0.449 |
|
| 2016 |
Bjørnevik K, Riise T, Benjaminsen E, Celius EG, Dahl OP, Kampman MT, Løken-Amsrud KI, Midgard R, Myhr KM, Torkildsen Ø, Vatne A, Grytten N. Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27207453 DOI: 10.1177/1352458516646863 |
0.416 |
|
| 2016 |
Keshari PK, Harbo HF, Myhr KM, Aarseth JH, Bos SD, Berge T. Allelic imbalance of multiple sclerosis susceptibility genes IKZF3 and IQGAP1 in human peripheral blood. Bmc Genetics. 17: 59. PMID 27080863 DOI: 10.1186/S12863-016-0367-4 |
0.401 |
|
| 2016 |
Torkildsen Ø, Myhr K, Bø L. Disease-modifying treatments for multiple sclerosis - a review of approved medications. European Journal of Neurology. 23: 18-27. PMID 26563094 DOI: 10.1111/Ene.12883 |
0.407 |
|
| 2016 |
Bjørnevik K, Riise T, Cortese M, Holmøy T, Kampman MT, Magalhaes S, Myhr KM, Wolfson C, Pugliatti M. Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study. Multiple Sclerosis (Houndmills, Basingstoke, England). 22: 104-11. PMID 26014605 DOI: 10.1177/1352458515579444 |
0.355 |
|
| 2015 |
Fazekas F, Gehring K, Gallo P, Lebrun-Frénay C, Moral E, Myhr KM. Country break-out session highlights. Neurodegenerative Disease Management. 5: 31-7. PMID 26611270 DOI: 10.2217/Nmt.15.58 |
0.445 |
|
| 2015 |
Kvistad SS, Myhr KM, Holmøy T, Šaltytė Benth J, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Bakke SJ, Michelsen AE, Aukrust P, Ueland T, et al. Body mass index influence interferon-beta treatment response in multiple sclerosis. Journal of Neuroimmunology. 288: 92-7. PMID 26531700 DOI: 10.1016/J.Jneuroim.2015.09.008 |
0.399 |
|
| 2015 |
Alme MN, Nystad AE, Bø L, Myhr KM, Vedeler CA, Wergeland S, Torkildsen Ø. Fingolimod does not enhance cerebellar remyelination in the cuprizone model. Journal of Neuroimmunology. 285: 180-6. PMID 26198937 DOI: 10.1016/J.Jneuroim.2015.06.006 |
0.307 |
|
| 2015 |
Kroksveen AC, Jaffe JD, Aasebø E, Barsnes H, Bjørlykke Y, Franciotta D, Keshishian H, Myhr KM, Opsahl JA, van Pesch V, Teunissen CE, Torkildsen Ø, Ulvik RJ, Vethe H, Carr SA, et al. Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis. Proteomics. 15: 3361-9. PMID 26152395 DOI: 10.1002/Pmic.201400142 |
0.378 |
|
| 2015 |
Grytten N, Torkildsen Ø, Myhr K. Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades Acta Neurologica Scandinavica. 132: 29-36. PMID 26046556 DOI: 10.1111/Ane.12428 |
0.479 |
|
| 2015 |
Magalhaes S, Pugliatti M, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Myhr KM, Parpinel M, Pekmezovic T, Riise T, Wolfson D, Zhu B, et al. The EnvIMS Study: Design and Methodology of an International Case-Control Study of Environmental Risk Factors in Multiple Sclerosis. Neuroepidemiology. 44: 173-81. PMID 25967369 DOI: 10.1159/000381779 |
0.458 |
|
| 2015 |
Cortese M, Riise T, Bjørnevik K, Holmøy T, Kampman MT, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM. Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 1856-64. PMID 25948625 DOI: 10.1177/1352458515578770 |
0.391 |
|
| 2015 |
Ragnedda G, Leoni S, Parpinel M, Casetta I, Riise T, Myhr KM, Wolfson C, Pugliatti M. Reduced duration of breastfeeding is associated with a higher risk of multiple sclerosis in both Italian and Norwegian adult males: the EnvIMS study. Journal of Neurology. 262: 1271-7. PMID 25794863 DOI: 10.1007/S00415-015-7704-9 |
0.416 |
|
| 2015 |
Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Šaltyt? Benth J, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, et al. Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis. Journal of Neuroimmunology. 280: 21-8. PMID 25773151 DOI: 10.1016/J.Jneuroim.2015.02.001 |
0.312 |
|
| 2015 |
Fjær S, Bø L, Myhr KM, Torkildsen Ø, Wergeland S. Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model. Neurochemistry International. 83: 28-40. PMID 25744931 DOI: 10.1016/J.Neuint.2015.02.006 |
0.302 |
|
| 2015 |
Grytten N, Aarseth JH, Lunde HM, Myhr K. A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway Journal of Neurology, Neurosurgery, and Psychiatry. 87: 100-105. PMID 25714916 DOI: 10.1136/Jnnp-2014-309906 |
0.394 |
|
| 2015 |
Goris A, Pauwels I, Gustavsen MW, van Son B, Hilven K, Bos SD, Celius EG, Berg-Hansen P, Aarseth J, Myhr KM, D'Alfonso S, Barizzone N, Leone MA, Martinelli Boneschi F, Sorosina M, et al. Genetic variants are major determinants of CSF antibody levels in multiple sclerosis. Brain : a Journal of Neurology. 138: 632-43. PMID 25616667 DOI: 10.1093/Brain/Awu405 |
0.319 |
|
| 2015 |
Kroksveen AC, Opsahl JA, Guldbrandsen A, Myhr KM, Oveland E, Torkildsen Ø, Berven FS. Cerebrospinal fluid proteomics in multiple sclerosis. Biochimica Et Biophysica Acta. 1854: 746-56. PMID 25526888 DOI: 10.1016/J.Bbapap.2014.12.013 |
0.461 |
|
| 2015 |
Sundal C, Baker M, Karrenbauer V, Gustavsen M, Bedri S, Glaser A, Myhr KM, Haugarvoll K, Zetterberg H, Harbo H, Kockum I, Hillert J, Wszolek Z, Rademakers R, Andersen O. Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 22: 328-33. PMID 25311247 DOI: 10.1111/Ene.12572 |
0.315 |
|
| 2015 |
Wesnes K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Lossius A, Magalhaes S, Pekmezovic T, Bjørnevik K, Wolfson C, Pugliatti M, ... Myhr KM, et al. Body size and the risk of multiple sclerosis in Norway and Italy: the EnvIMS study. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 388-95. PMID 25182290 DOI: 10.1177/1352458514546785 |
0.408 |
|
| 2015 |
Westerlind H, Imrell K, Ramanujam R, Myhr KM, Celius EG, Harbo HF, Oturai AB, Hamsten A, Alfredsson L, Olsson T, Kockum I, Koski T, Hillert J. Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort. European Journal of Human Genetics : Ejhg. 23: 688-92. PMID 25159868 DOI: 10.1038/Ejhg.2014.155 |
0.406 |
|
| 2014 |
Holmøy T, Myhr KM, Bø L. [Re: Unethical of neurologists not to offer patients with multiple sclerosis chemotherapy with autologous stem cell support]. Tidsskrift For Den Norske Laegeforening : Tidsskrift For Praktisk Medicin, Ny Raekke. 134: 2239-40. PMID 25492327 DOI: 10.4045/Tidsskr.14.1458 |
0.334 |
|
| 2014 |
Torkildsen O, Aarseth J, Celius EG, Holmøy T, Kampman MT, Løken-Amsrud KI, Midgard R, Myhr KM, Riise T, Grytten N. Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments. Annals of Clinical and Translational Neurology. 1: 376-7. PMID 25356407 DOI: 10.1002/Acn3.56 |
0.361 |
|
| 2014 |
Torkildsen O, Aarseth J, Benjaminsen E, Celius E, Holmøy T, Kampman MT, Løken-Amsrud K, Midgard R, Myhr KM, Riise T, Grytten N. Month of birth and risk of multiple sclerosis: confounding and adjustments. Annals of Clinical and Translational Neurology. 1: 141-4. PMID 25356394 DOI: 10.1002/Acn3.37 |
0.415 |
|
| 2014 |
Torkildsen O, Myhr KM, Wergeland S. Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS. Neurology(R) Neuroimmunology & Neuroinflammation. 1: e25. PMID 25340078 DOI: 10.1212/Nxi.0000000000000025 |
0.403 |
|
| 2014 |
Bøe Lunde HM, Telstad W, Grytten N, Kyte L, Aarseth J, Myhr KM, Bø L. Employment among patients with multiple sclerosis-a population study. Plos One. 9: e103317. PMID 25054972 DOI: 10.1371/Journal.Pone.0103317 |
0.475 |
|
| 2014 |
Gustavsen MW, Viken MK, Celius EG, Berge T, Mero IL, Berg-Hansen P, Aarseth JH, Myhr KM, Søndergaard HB, Sellebjerg F, Oturai AB, Hillert J, Alfredsson L, Olsson T, Kockum I, et al. Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general. Journal of Neuroimmunology. 274: 174-9. PMID 25037176 DOI: 10.1016/J.Jneuroim.2014.06.024 |
0.371 |
|
| 2014 |
Kvistad S, Myhr KM, Holmøy T, Bakke S, Beiske AG, Bjerve KS, Hovdal H, Løken-Amsrud KI, Lilleås F, Midgard R, Njølstad G, Pedersen T, Benth JŠ, Wergeland S, Torkildsen O. Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1833-40. PMID 24842958 DOI: 10.1177/1352458514533843 |
0.406 |
|
| 2014 |
Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, et al. Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis. Journal of Neuroimmunology. 271: 60-5. PMID 24713402 DOI: 10.1016/J.Jneuroim.2014.03.014 |
0.325 |
|
| 2014 |
Gavasso S, Mosleth EF, Marøy T, Jørgensen K, Nakkestad HL, Gjertsen BT, Myhr KM, Vedeler C. Deficient phosphorylation of Stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-beta. Plos One. 9: e88632. PMID 24586361 DOI: 10.1371/Journal.Pone.0088632 |
0.346 |
|
| 2014 |
Jacobsen C, Hagemeier J, Myhr KM, Nyland H, Lode K, Bergsland N, Ramasamy DP, Dalaker TO, Larsen JP, Farbu E, Zivadinov R. Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study Journal of Neurology, Neurosurgery, and Psychiatry. 85: 1109-1115. PMID 24554101 DOI: 10.1136/Jnnp-2013-306906 |
0.569 |
|
| 2014 |
Olberg HK, Cox RJ, Nostbakken JK, Aarseth JH, Vedeler CA, Myhr KM. Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1074-80. PMID 24436455 DOI: 10.1177/1352458513513970 |
0.329 |
|
| 2014 |
Bjørnevik K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Lossius A, Magalhaes S, Myhr KM, Pekmezovic T, Wesnes K, Wolfson C, et al. Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1042-9. PMID 24414538 DOI: 10.1177/1352458513513968 |
0.411 |
|
| 2014 |
Lossius A, Riise T, Pugliatti M, Bjørnevik K, Casetta I, Drulovic J, Granieri E, Kampman MT, Landtblom AM, Lauer K, Magalhaes S, Myhr KM, Pekmezovic T, Wesnes K, Wolfson C, et al. Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 669-74. PMID 24072723 DOI: 10.1177/1352458513505693 |
0.405 |
|
| 2013 |
Fjær S, Bø L, Lundervold A, Myhr KM, Pavlin T, Torkildsen O, Wergeland S. Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model. Plos One. 8: e84162. PMID 24386344 DOI: 10.1371/Journal.Pone.0084162 |
0.336 |
|
| 2013 |
Salzer J, Myhr KM. Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: no. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1692-3. PMID 24218487 DOI: 10.1177/1352458513507625 |
0.327 |
|
| 2013 |
Leone MA, Barizzone N, Esposito F, Lucenti A, Harbo HF, Goris A, Kockum I, Oturai AB, Celius EG, Mero IL, Dubois B, Olsson T, Søndergaard HB, Cusi D, Lupoli S, ... ... Myhr KM, et al. Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients. Plos One. 8: e64408. PMID 23785401 DOI: 10.1371/Journal.Pone.0064408 |
0.337 |
|
| 2013 |
Mero IL, Gustavsen MW, Sæther HS, Flåm ST, Berg-Hansen P, Søndergaard HB, Jensen PE, Berge T, Bjølgerud A, Muggerud A, Aarseth JH, Myhr KM, Celius EG, Sellebjerg F, et al. Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles. Plos One. 8: e58352. PMID 23472185 DOI: 10.1371/Journal.Pone.0058352 |
0.457 |
|
| 2013 |
Ban M, Caillier S, Mero IL, Myhr KM, Celius EG, Aarseth J, Torkildsen Ø, Harbo HF, Oksenberg J, Hauser SL, Sawcer S, Compston A. No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis. Annals of Neurology. 73: 430-2. PMID 23444327 DOI: 10.1002/Ana.23833 |
0.355 |
|
| 2013 |
Løken-Amsrud KI, Myhr KM, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JŠ, Torkildsen Ø, Wergeland S, Holmøy T. Alpha-tocopherol and MRI outcomes in multiple sclerosis--association and prediction. Plos One. 8: e54417. PMID 23349882 DOI: 10.1371/Journal.Pone.0054417 |
0.367 |
|
| 2013 |
Kampman MT, Aarseth JH, Grytten N, Benjaminsen E, Celius EG, Dahl OP, Holmøy T, Løken-Amsrud K, Midgard R, Myhr KM, Risberg G, Vatne A, Torkildsen O. Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway. Journal of Neurology. 260: 1481-8. PMID 23292231 DOI: 10.1007/S00415-012-6814-X |
0.444 |
|
| 2013 |
Grytten N, Torkildsen Ø, Aarseth JH, Benjaminsen E, Celius EG, Dahl OP, Holmøy T, Løken-Amsrud K, Midgard R, Myhr KM, Risberg G, Vatne A, Kampman MT. Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1028-34. PMID 23257620 DOI: 10.1177/1352458512471094 |
0.437 |
|
| 2013 |
Kroksveen AC, Aasebø E, Vethe H, Van Pesch V, Franciotta D, Teunissen CE, Ulvik RJ, Vedeler C, Myhr KM, Barsnes H, Berven FS. Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM. Journal of Proteomics. 78: 312-25. PMID 23059536 DOI: 10.1016/J.Jprot.2012.09.037 |
0.386 |
|
| 2012 |
Pugliatti M, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Myhr K, Parpinel M, Pekmezovic T, Riise T, Zhu B, Wolfson C. A questionnaire for multinational case–control studies of environmental risk factors in multiple sclerosis (EnvIMS‐Q) Acta Neurologica Scandinavica. 126: 43-50. PMID 23278656 DOI: 10.1111/Ane.12032 |
0.418 |
|
| 2012 |
Pugliatti M, Eskic D, Mikolcić T, Pitschnau-Michel D, Myhr KM, Sastre-Garriga J, Otero S, Wieczynska L, Torje C, Holloway E, Rienhoff O, Friede T, Buckow K, Ellenberger D, Hillert J, et al. Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS. Acta Neurologica Scandinavica. Supplementum. 24-30. PMID 23278653 DOI: 10.1111/Ane.12024 |
0.456 |
|
| 2012 |
Myhr K, Grytten N, Torkildsen Ø, Wergeland S, Bø L, Pugliatti M, Aarseth JH. A need for national registries and international collaborative research in multiple sclerosis. Acta Neurologica Scandinavica. 126: 1-3. PMID 23278648 DOI: 10.1111/Ane.12039 |
0.463 |
|
| 2012 |
Bøe Lunde HM, Aae TF, Indrevåg W, Aarseth J, Bjorvatn B, Myhr KM, Bø L. Poor sleep in patients with multiple sclerosis. Plos One. 7: e49996. PMID 23166808 DOI: 10.1371/Journal.Pone.0049996 |
0.35 |
|
| 2012 |
Løken-Amsrud KI, Holmøy T, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Sandvik L, Torkildsen O, Wergeland S, Myhr KM. Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment. Neurology. 79: 267-73. PMID 22700809 DOI: 10.1212/Wnl.0B013E31825Fdf01 |
0.344 |
|
| 2012 |
Torkildsen O, Wergeland S, Bakke S, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Lilleås F, Pedersen T, Bjørnarå B, Dalene F, Kleveland G, Schepel J, Olsen IC, Myhr KM. ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial. Archives of Neurology. 69: 1044-51. PMID 22507886 DOI: 10.1001/Archneurol.2012.283 |
0.332 |
|
| 2012 |
Mero IL, Smestad C, Lie BA, Lorentzen ÅR, Sandvik L, Landrø NI, Aarseth JH, Myhr KM, Celius EG, Harbo HF. Polymorphisms of the BDNF gene show neither association with multiple sclerosis susceptibility nor clinical course. Journal of Neuroimmunology. 244: 107-10. PMID 22341604 DOI: 10.1016/J.Jneuroim.2012.01.011 |
0.417 |
|
| 2012 |
Gavasso S, Gjertsen B, Anderssen E, Myhr K, Vedeler C. Immunogenic effects of recombinant interferon-beta therapy disrupt the JAK/STAT pathway in primary immune cells from patients with multiple sclerosis: Multiple Sclerosis Journal. 18: 1116-1124. PMID 22287540 DOI: 10.1177/1352458511434066 |
0.317 |
|
| 2012 |
Svendsen B, Myhr K, Nyland HI, Aarseth JH. The cost of multiple sclerosis in Norway European Journal of Health Economics. 13: 81-91. PMID 21080024 DOI: 10.1007/S10198-010-0286-7 |
0.558 |
|
| 2011 |
Søndergaard HB, Sellebjerg F, Hillert J, Olsson T, Kockum I, Lindén M, Mero IL, Myhr KM, Celius EG, Harbo HF, Christensen JR, Börnsen L, Sørensen PS, Oturai AB. Alterations in KLRB1 gene expression and a Scandinavian multiple sclerosis association study of the KLRB1 SNP rs4763655 European Journal of Human Genetics. 19: 1100-1103. PMID 21610746 DOI: 10.1038/Ejhg.2011.88 |
0.455 |
|
| 2011 |
Sørensen PS, Jensen PE, Haghikia A, Lundkvist M, Vedeler C, Sellebjerg F, Koch-Henriksen N, Fogdell-Hahn A, Myhr KM, Hillert J, Gold R. Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 1074-8. PMID 21511692 DOI: 10.1177/1352458511404271 |
0.406 |
|
| 2011 |
Riise T, Kirkeleit J, Aarseth JH, Farbu E, Midgard R, Mygland Å, Eikeland R, Mørland TJ, Telstad W, Førland PT, Myhr KM. Risk of MS is not associated with exposure to crude oil, but increases with low level of education. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 780-7. PMID 21343231 DOI: 10.1177/1352458510397686 |
0.37 |
|
| 2011 |
Risberg G, Aarseth JH, Nyland H, Lauer K, Myhr KM, Midgard R. Prevalence and incidence of multiple sclerosis in Oppland County: a cross-sectional population-based study in a landlocked county of Eastern Norway. Acta Neurologica Scandinavica. 124: 250-7. PMID 21143594 DOI: 10.1111/J.1600-0404.2010.01465.X |
0.642 |
|
| 2011 |
Glad SB, Nyland H, Aarseth JH, Riise T, Myhr KM. How long can you keep working with benign multiple sclerosis? Journal of Neurology, Neurosurgery, and Psychiatry. 82: 78-82. PMID 20802029 DOI: 10.1136/Jnnp.2010.210732 |
0.66 |
|
| 2010 |
Ramagopalan SV, Hanwell HE, Giovannoni G, Knappskog PM, Nyland HI, Myhr KM, Ebers GC, Torkildsen O. Vitamin D-dependent rickets, HLA-DRB1, and the risk of multiple sclerosis. Archives of Neurology. 67: 1034-5. PMID 20697062 DOI: 10.1001/Archneurol.2010.182 |
0.569 |
|
| 2010 |
Lorentzen AR, Melum E, Ellinghaus E, Smestad C, Mero IL, Aarseth JH, Myhr KM, Celius EG, Lie BA, Karlsen TH, Franke A, Harbo HF. Association to the Glypican-5 gene in multiple sclerosis. Journal of Neuroimmunology. 226: 194-7. PMID 20692050 DOI: 10.1016/J.Jneuroim.2010.07.003 |
0.45 |
|
| 2010 |
Rajalahti T, Kroksveen AC, Arneberg R, Berven FS, Vedeler CA, Myhr KM, Kvalheim OM. A multivariate approach to reveal biomarker signatures for disease classification: application to mass spectral profiles of cerebrospinal fluid from patients with multiple sclerosis. Journal of Proteome Research. 9: 3608-20. PMID 20499859 DOI: 10.1021/Pr100142M |
0.372 |
|
| 2010 |
Naess H, Glad S, Storstein A, Rinaldo CH, Mørk SJ, Myhr KM, Hirsch H. Progressive multifocal leucoencephalopathy in an immunocompetent patient with favourable outcome. A case report. Bmc Neurology. 10: 32. PMID 20482768 DOI: 10.1186/1471-2377-10-32 |
0.559 |
|
| 2010 |
Naess H, Sundal E, Myhr KM, Nyland HI. Postinfectious and chronic fatigue syndromes: clinical experience from a tertiary-referral centre in Norway. In Vivo (Athens, Greece). 24: 185-8. PMID 20363992 |
0.62 |
|
| 2010 |
Myhr KM. [Pharmacological treatment of multiple sclerosis]. Tidsskrift For Den Norske Laegeforening : Tidsskrift For Praktisk Medicin, Ny Raekke. 130: 490-2. PMID 20224616 DOI: 10.4045/Tidsskr.09.1126 |
0.336 |
|
| 2010 |
Torkildsen Ø, Stansberg C, Angelskår SM, Kooi EJ, Geurts JJ, van der Valk P, Myhr KM, Steen VM, Bø L. Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. Brain Pathology (Zurich, Switzerland). 20: 720-9. PMID 19919606 DOI: 10.1111/J.1750-3639.2009.00343.X |
0.424 |
|
| 2010 |
Mero IL, Lorentzen AR, Ban M, Smestad C, Celius EG, Aarseth JH, Myhr KM, Link J, Hillert J, Olsson T, Kockum I, Masterman T, Oturai AB, Søndergaard HB, Sellebjerg F, et al. A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis. European Journal of Human Genetics : Ejhg. 18: 502-4. PMID 19888296 DOI: 10.1038/Ejhg.2009.195 |
0.44 |
|
| 2009 |
Glad S, Nyland H, Aarseth J, Riise T, Myhr K. Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway. Multiple Sclerosis Journal. 15: 942-950. PMID 19570821 DOI: 10.1177/1352458509106511 |
0.675 |
|
| 2009 |
Myhr KM. Vitamin D treatment in multiple sclerosis. Journal of the Neurological Sciences. 286: 104-8. PMID 19549608 DOI: 10.1016/J.Jns.2009.05.002 |
0.449 |
|
| 2009 |
Aarskog NK, Marøy T, Myhr KM, Vedeler CA. Antibodies against interferon-beta in multiple sclerosis. Journal of Neuroimmunology. 212: 148-50. PMID 19467718 DOI: 10.1016/J.Jneuroim.2009.04.012 |
0.342 |
|
| 2009 |
Sorensen PS, Mellgren SI, Svenningsson A, Elovaara I, Frederiksen JL, Beiske AG, Myhr KM, Søgaard LV, Olsen IC, Sandberg-Wollheim M. NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial. The Lancet. Neurology. 8: 519-29. PMID 19409854 DOI: 10.1016/S1474-4422(09)70085-7 |
0.352 |
|
| 2009 |
Lode K, Bru E, Klevan G, Myhr K, Nyland H, Larsen J. Depressive symptoms and coping in newly diagnosed patients with multiple sclerosis Multiple Sclerosis Journal. 15: 638-643. PMID 19299438 DOI: 10.1177/1352458509102313 |
0.622 |
|
| 2008 |
Figved N, Benedict R, Klevan G, Myhr KM, Nyland HI, Landrø NI, Larsen JP, Aarsland D. Relationship of cognitive impairment to psychiatric symptoms in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 1084-90. PMID 18728059 DOI: 10.1177/1352458508092262 |
0.617 |
|
| 2008 |
Torkildsen NG, Lie S, Aarseth J, Nyland H, Myhr K. Survival and cause of death in multiple sclerosis : results from a 50-year follow-up in Western Norway Multiple Sclerosis Journal. 14: 1191-1198. PMID 18632781 DOI: 10.1177/1352458508093890 |
0.618 |
|
| 2008 |
Lorentzen AR, Smestad C, Lie BA, Oturai AB, Akesson E, Saarela J, Myhr KM, Vartdal F, Celius EG, Sørensen PS, Hillert J, Spurkland A, Harbo HF. The SH2D2A gene and susceptibility to multiple sclerosis. Journal of Neuroimmunology. 197: 152-8. PMID 18554728 DOI: 10.1016/J.Jneuroim.2008.04.037 |
0.424 |
|
| 2008 |
Torkildsen Ø, Knappskog PM, Nyland HI, Myhr KM. Vitamin D-dependent rickets as a possible risk factor for multiple sclerosis. Archives of Neurology. 65: 809-11. PMID 18541802 DOI: 10.1001/Archneur.65.6.809 |
0.597 |
|
| 2008 |
Pugliatti M, Harbo HF, Holmøy T, Kampman MT, Myhr K, Riise T, Wolfson C. Environmental risk factors in multiple sclerosis. Acta Neurologica Scandinavica. 117: 34-40. PMID 18439219 DOI: 10.1111/J.1600-0404.2008.01029.X |
0.468 |
|
| 2008 |
Myhr KM. Diagnosis and treatment of multiple sclerosis. Acta Neurologica Scandinavica. Supplementum. 188: 12-21. PMID 18439216 DOI: 10.1111/J.1600-0404.2008.01026.X |
0.437 |
|
| 2008 |
Dahl J, Myhr KM, Daltveit AK, Gilhus NE. Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis. Journal of Neurology. 255: 623-7. PMID 18283397 DOI: 10.1007/S00415-008-0757-2 |
0.444 |
|
| 2008 |
Yu X, Koczan D, Sulonen AM, Akkad DA, Kroner A, Comabella M, Costa G, Corongiu D, Goertsches R, Camina-Tato M, Thiesen HJ, Nyland HI, Mørk SJ, Montalban X, Rieckmann P, ... ... Myhr KM, et al. mtDNA nt13708A variant increases the risk of multiple sclerosis. Plos One. 3: e1530. PMID 18270557 DOI: 10.1371/Journal.Pone.0001530 |
0.617 |
|
| 2007 |
Harbo HF, Mørk S, Vedeler C, Myhr KM. [Multiple sclerosis biobank established]. Tidsskrift For Den Norske Laegeforening : Tidsskrift For Praktisk Medicin, Ny Raekke. 127: 2276. PMID 17828328 |
0.36 |
|
| 2007 |
Figved N, Myhr K, Larsen J, Aarsland D. Caregiver burden in multiple sclerosis: the impact of neuropsychiatric symptoms Journal of Neurology, Neurosurgery, and Psychiatry. 78: 1097-1102. PMID 17237144 DOI: 10.1136/Jnnp.2006.104216 |
0.44 |
|
| 2006 |
Naess H, Waje-Andreassen U, Thomassen L, Myhr KM. High incidence of infarction in the left cerebral hemisphere among young adults. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 15: 241-4. PMID 17904082 DOI: 10.1016/J.Jstrokecerebrovasdis.2006.06.003 |
0.516 |
|
| 2006 |
Smedal T, Lygren H, Myhr KM, Moe-Nilssen R, Gjelsvik B, Gjelsvik O, Strand LI, Inger L. Balance and gait improved in patients with MS after physiotherapy based on the Bobath concept. Physiotherapy Research International : the Journal For Researchers and Clinicians in Physical Therapy. 11: 104-16. PMID 16808091 DOI: 10.1002/Pri.327 |
0.428 |
|
| 2006 |
Naess H, Waje-Andreassen U, Thomassen L, Nyland H, Myhr KM. Health-related quality of life among young adults with ischemic stroke on long-term follow-up. Stroke. 37: 1232-6. PMID 16601213 DOI: 10.1161/01.Str.0000217652.42273.02 |
0.638 |
|
| 2005 |
Naess H, Nyland HI, Thomassen L, Aarseth J, Myhr KM. Fatigue at long-term follow-up in young adults with cerebral infarction. Cerebrovascular Diseases (Basel, Switzerland). 20: 245-50. PMID 16123544 DOI: 10.1159/000087706 |
0.642 |
|
| 2005 |
Lorentzen AR, Celius EG, Ekstrøm PO, Wiencke K, Lie BA, Myhr KM, Ling V, Thorsby E, Vartdal F, Spurkland A, Harbo HF. Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients. Journal of Neuroimmunology. 166: 197-201. PMID 16005527 DOI: 10.1016/J.Jneuroim.2005.06.002 |
0.418 |
|
| 2005 |
van Sorge NM, van der Pol WL, Jansen MD, Geleijns KP, Kalmijn S, Hughes RA, Rees JH, Pritchard J, Vedeler CA, Myhr KM, Shaw C, van Schaik IN, Wokke JH, van Doorn PA, Jacobs BC, et al. Severity of Guillain-Barré syndrome is associated with Fc gamma Receptor III polymorphisms. Journal of Neuroimmunology. 162: 157-64. PMID 15833371 DOI: 10.1016/J.Jneuroim.2005.01.016 |
0.306 |
|
| 2004 |
Oturai AB, Ryder LP, Fredrikson S, Myhr KM, Celius EG, Harbo HF, Andersen O, Akesson E, Hillert J, Madsen HO, Nyland H, Spurkland A, Datta P, Svejgaard A, Sorensen PS. Concordance for disease course and age of onset in Scandinavian multiple sclerosis coaffected sib pairs. Multiple Sclerosis (Houndmills, Basingstoke, England). 10: 5-8. PMID 14760946 DOI: 10.1191/1352458504Ms975Oa |
0.63 |
|
| 2003 |
Myhr KM, Harbo HF. [Multiple sclerosis--a disease with complex genetics]. Tidsskrift For Den Norske Laegeforening : Tidsskrift For Praktisk Medicin, Ny Raekke. 123: 2723-6. PMID 14600746 |
0.322 |
|
| 2003 |
Harbo HF, Datta P, Oturai A, Ryder LP, Sawcer S, Setakis E, Akesson E, Celius EG, Modin H, Sandberg-Wollheim M, Myhr KM, Andersen O, Hillert J, Sorensen PS, Svejgaard A, et al. Two genome-wide linkage disequilibrium screens in Scandinavian multiple sclerosis patients. Journal of Neuroimmunology. 143: 101-6. PMID 14575924 DOI: 10.1016/J.Jneuroim.2003.08.021 |
0.358 |
|
| 2003 |
Eriksen E, Haugstad R, Aarseth JH, Myhr K, Nyland H. Interferon-beta Treatment in Multiple Sclerosis; Patients’ Experience in the First 100 Patients Acta Neurologica Scandinavica. 107: 429-430. DOI: 10.1034/J.1600-0404.2003.00125_9.X |
0.585 |
|
| 2002 |
Fernandes Filho JA, Vedeler CA, Myhr KM, Nyland H, Pandey JP. TNF-alpha and -beta gene polymorphisms in multiple sclerosis: a highly significant role for determinants in the first intron of the TNF-beta gene. Autoimmunity. 35: 377-80. PMID 12568117 DOI: 10.1080/0891693021000021549 |
0.542 |
|
| 2002 |
Myhr KM, Vågnes KS, Marøy TH, Aarseth JH, Nyland HI, Vedeler CA. Interleukin-10 promoter polymorphisms in patients with multiple sclerosis. Journal of the Neurological Sciences. 202: 93-7. PMID 12220699 DOI: 10.1016/S0022-510X(02)00246-0 |
0.628 |
|
| 2001 |
Vedeler CA, Myhr K, Nyland H. Fc receptors for immunoglobulin G--a role in the pathogenesis of Guillain-Barré syndrome and multiple sclerosis. Journal of Neuroimmunology. 118: 187-193. PMID 11498253 DOI: 10.1016/S0165-5728(01)00344-7 |
0.59 |
|
| 2000 |
Nortvedt MW, Riise T, Myhr K, Nyland HI. Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis population. Medical Care. 38: 1022-1028. PMID 11021675 DOI: 10.1097/00005650-200010000-00006 |
0.578 |
|
| 2000 |
Vedeler CA, Raknes G, Myhr K, Nyland H. IgG Fc-receptor polymorphisms in Guillain-Barré syndrome. Neurology. 55: 705-707. PMID 10980740 DOI: 10.1212/Wnl.55.5.705 |
0.551 |
|
| 2000 |
Nortvedt MW, Riise T, Myhr K, Nyland HI. Quality of life as a predictor for change in disability in MS Neurology. 55: 51-54. PMID 10891905 DOI: 10.1212/Wnl.55.1.51 |
0.609 |
|
| 1999 |
Nortvedt MW, Riise T, Myhr K, Nyland HI. Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology. 53: 1098-1098. PMID 10496273 DOI: 10.1212/Wnl.53.5.1098 |
0.631 |
|
| 1999 |
Myhr K, Raknes G, Nyland H, Vedeler C. Immunoglobulin G Fc-receptor (FcγR) IIA and IIIB polymorphisms related to disability in MS Neurology. 52: 1771-1771. PMID 10371522 DOI: 10.1212/Wnl.52.9.1771 |
0.659 |
|
| 1998 |
Myhr KM, Riise T, Barrett-Connor E, Myrmel H, Vedeler C, Grønning M, Kalvenes MB, Nyland H. Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway. Journal of Neurology, Neurosurgery, and Psychiatry. 64: 539-42. PMID 9576551 DOI: 10.1136/Jnnp.64.4.539 |
0.562 |
|
| Show low-probability matches. |